The U.S. Food and Drug Administration announced that a Johnson and Johnson foot gel that is used by diabetics may increase the risk of cancer.
The gel, Regranex, was found to increase the number of cancer deaths of people who had previously been prescribed the gel 3 or more times.
"At this time, FDA believes that there may be some evidence for an increased risk of death from cancer in patients who had repeated treatments with Regranex," the FDA said in a statement. "Because there are known risks associated with diabetic foot and leg ulcers that do not heal, the potential risk of using Regranex should be weighed against the benefit for each individual patient."
[Source: YahooNews]
» FDA Adds Warning to Regranex from PharmaGazette
Johnson & Johnson's foot ulcer medication, Regranex, has had a U.S. Food and Drug Administration warning added to its label stating that using large amounts of the cream could increase the risk of cancer.The warning, the FDA's strongest, st... [Read More]
Tracked on: June 11, 2008 2:05 PM | Permalink to Trackback